Editor's Correspondence |

Diagnostic Accuracy of Natriuretic Peptides for Heart Failure—Reply

Jenny A. Doust, BMBS, FRACGP; Paul P. Glasziou, FRACGP, PhD; Annette J. Dobson, PhD
Arch Intern Med. 2005;165(10):1199. doi:10.1001/archinte.165.10.1199-a.
Text Size: A A A
Published online


In reply

In the March 28 issue of the ARCHIVES, Battalgia et al1 raised 3 issues related to our recent review of the diagnostic accuracy of natriuretic peptides.2 First, they were aware of 4 studies of the rapid enzyme-linked immunosorbent assay (ELISA) form of the test that were not included in our review. It is not clear from their letter if these studies were published before or after the search date for our review, December 2002. We excluded 5 studies from our review that had used the rapid ELISA form of the test because the dates of recruitment and the recruitment sites overlapped with those of the studies by Maisel et al, 2002,3 and Krishnaswamy et al, 2001.4 We have also recently updated the review (search date, March 2004) and found a further 2 studies that used the rapid ELISA form of the test. We agree with the correspondents that the type of assay may be one reason for the significant heterogeneity seen in the test characteristics between the studies. One difficulty in determining this, however, is that there are no studies, to our knowledge, comparing these 2 forms of the test within 1 population. The results of any comparison made between studies would need to be interpreted with considerable caution. Of interest, we are currently conducting a study of the variability of 2 versions of the test. The 2 forms of the test are showing considerable and inconsistent variability.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles